A new study reveals that the use of psychedelic-assisted therapy for treating depression and anxiety shows promising early results, with participants reporting significant reductions in symptoms after just a single session. Researchers emphasize that these findings, while preliminary, suggest potential for a groundbreaking shift in mental health treatment, particularly for patients unresponsive to conventional therapies. The study highlights the need for further investigation into dosage, safety, and long-term effects before widespread adoption. Critics caution that more rigorous trials are essential to validate these outcomes and ensure proper regulation.